Key result
NSAIDs and other antipyretics used to manage post-vaccination symptoms are proposed as a potential overlooked trigger for vaccine-associated myocarditis.
Answers are grounded in this paper and cite their sources.
This editorial highlights the critical need to systematically collect data on NSAID and antipyretic use following COVID-19 vaccination to investigate their potential role in triggering or exacerbating vaccine-associated myocarditis.
Buoninfante et al. provide a comprehensive overview of possible mechanisms involved in the development of myocarditis following COVID-19 vaccination. They also suggest next steps to further understand the pathophysiology of this disease; however, one common factor has been overlooked. As myocarditis most often occurs in adolescent and young adult males, medications have not played a prominent role in this investigation, as medication use in this age group is uncommon; however, there is one notable exception: use of antipyretics.
No takes yet. Share an insight, caveat, or question.
Stephen A. Hoption Cann (2025) conducted a letter in Vaccine-associated myocarditis. NSAIDs and antipyretics was evaluated. NSAIDs and other antipyretics used to manage post-vaccination symptoms are proposed as a potential overlooked trigger for vaccine-associated myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: